CSFB launches $75m High Medical IPO

Premarketing got underway today (Wednesday) for the $75m IPO of Swiss medical devices manufacturer High Medical Technologies.

  • 09 Mar 2001
Email a colleague
Request a PDF
The company, which specialises in equipment for urology and orthopaedics departments, will list on the SWX New Market. Credit Suisse First Boston is sole bookrunner for the deal.

The company is planning to sell 390m shares in the base offering and 59m in the greenshoe. The total offering represents 53% of the company. The price range for the deal will be announced on March 26.

Of the issue, about half will be capital increase and half will be secondary. "The company is going to use the proceeds to finance internal growth, enter further collaboration arrangements and commission scientific and clinical surveys," said a banker close to the deal.

Bank Sarasin, Lombard Odier and Kantonalbank are co-managers.

  • 09 Mar 2001

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 357,043.08 1340 9.06%
2 JPMorgan 319,078.96 1445 8.09%
3 Bank of America Merrill Lynch 316,666.04 1099 8.03%
4 Goldman Sachs 236,643.87 789 6.00%
5 Barclays 230,494.28 891 5.85%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 HSBC 34,591.50 163 6.58%
2 Deutsche Bank 34,293.84 117 6.53%
3 Bank of America Merrill Lynch 31,293.04 95 5.96%
4 BNP Paribas 27,578.61 168 5.25%
5 SG Corporate & Investment Banking 23,982.83 136 4.56%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 19,745.92 80 8.86%
2 Morgan Stanley 16,323.54 83 7.32%
3 Citi 15,946.50 94 7.15%
4 UBS 15,487.17 60 6.95%
5 Goldman Sachs 14,053.61 76 6.30%